Trial
NCT01767857
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Janssen Research & Development, LLC
Collaborators
—
Condition
Metastatic Colorectal Cancer
Intervention
Xilonix
Why stopped
The study crossed the prospective futility boundary of primary endpoint
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-29